Catalyst Wire Dossier Catalyst Wire Dossier

TAZICEF

CEFTAZIDIME · Hospira, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TAZICEF, covering 2012-03-12 to 2022-03-03. Get the full timeline:

Most recent: FDA Approved: TAZICEF — Supplemental Application (Hospira, Inc.)

See pricing